Manifestations cliniques des infections à Chlamydia pneumoniae

Revue de Medecine Interne

Volumn 17, Issue SUPPL. 1, 1996, Pages

  Gaillat, J ^a  

^a Centre Hospitalier de la Region d'Annecy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; HUMAN; RESPIRATORY TRACT INFECTION; SYMPTOMATOLOGY;

CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; PNEUMONIA, BACTERIAL;

EID: 0029891732     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)86504-0     Document Type: Article

References (35)

1. Grayston JT, Wang SP, Kuo CC, Mordhorst CH, Saikku P, Marrie TJ. Seroepidemiology with TWAR, a new group of Chlamydia psittaci [Abstract], 24th meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, 8-10 Octobre, 1984
2. Cook PJ, Honeybourne D. Clinical aspects of Chlamydia pneumoniae infection. Presse Méd 1995;24:278-81
3. Aldous MB, GraystonJT, Wang SP, Foy HM. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle Families. 1966-1979. J Infect Dis 1992;166:646-9
4. Einarsson S, Sigurdsson H, Magnusdottir, Eldendstottir H, Briem H, Gudmundsson S. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scan J Infect Dis 1994;26:393-7
5. Eb F, Orfila J, Corbel C. Diagnostic des infections respiratoires dues aux souches TWAR (Chlamydia pneumoniae) et prévalence des anticorps anti-TWAR. Étude de 210 sérums. Med Mal Inf 1989;19:430-4
6. Joubin E. Incidence de la pneumonie à Chlamydia pneumoniae : à propos de 113 cas de pneumonies admis à l'hôpital d'Annecy en 1993. Thèse de médecine Université de Grenoble 1994
7. Gaydos CA, Eiden JJ, Oldach D et al. Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin Infect Dis 1994;19:471-7
8. Block S, Hedrick J, Hammerschlag M, Gail G, Craft J. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate. Pediatr Infect Dis J 1995;14:471-7
9. Grayston TJ, Kuo C, Wang SP, Altman J. A new Chlamydia psittaci, TWAR, isolated in respiratory tract infection. N Engl J Med 1986;315:161-8
10. Grayston JT, Diwan VK, Cooney M, Wang SP, Community and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med 1989;149: 169-73
11. Almiral J, Morato I, Verdaguer A et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J 1993;6:14-8
12. Grayston JT. Chlamydia pneumoniae strain TWAR pneumonia. Ann Rev Med 1992;43:317-23
13. Blasi F, Cosentini R, Legani D, Denti F, Allegra L. Incidence of community acquired pneumonia caused by Chlamydia pneumoniae in Italian patients. Eur J Clin Microbiol Infect Dis 1993; 12: 696-9
14. Steihoff D, Heindrich B, Rolfs A, Fehrenbrach FJ. Ruckdeschel G, Lode H. Microbial etiology, clinical and therapeutical aspects of community-acquired pneumonia, a one year multicentre study in Berlin [Abstract 1376]. 32nd meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans DC, 8-10 octobre, 1992
15. Gaydos CA, Roblin PM, Hammerschlag M et al. Diagnosis utility of PCR immunoassay, culture and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994;32:903-5
16. Thom D, Grayston JT. Infections with Chlamvdia pneumoniae strainTWAR. Clin Chest Med 1991;12:245-56
17. Grayston JT, Campbell L A, Kuo CC, Diwan VK, Wang SP. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25
18. Thom DH, Grayston JT, Campbell LA, Kuo CC, Diwan VK, Wang SP. Respiratory infection with Chlamydia pneumoniae in middle-aged an older adults outpatients. Eur J Clin Microbiol Infect Dis 1994;13:785-92
19. Allegra L, Blasi F, Centanni S et al. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur J Clin Microbiol Infect Dis 1994;7:2165-8
20. Hahn DL, Dodge R, Golubjatnikov R. Association of Chlamydia pneumoniae (strainTWAR) infection with wheezing, asthmatic bronchitis and adult onset asthma. J Am Med Association 1991; 266:225-30
21. Beaty C, Grayston JT. Wazng SP, Kuo CC, Reto C, Martin TR. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 144:1408-10
22. McConnell CT, Plouffe JF, File TM et al. Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. Radiology 1994;192:819-24
23. Sven H, Ivarsson S, Bjerre I, Persson K. Guillain Barré syndrome after Chlamydia pneumoniae infection. N Eng J Med 1992;326:576-7
24. Soçan M, Beovic B. Chlamydia pneumoniae and meningoencephalitis. N Eng J Med 1994;331:406
25. Michel D, Antoine JC, Porzetto B, Gaudin OG, Lucht F. Lombosacral meningoradiculitis associated with Chlamydia pneumoniae infection. J Neurol Neuroneurg Psychiatr 1992;55:511
26. Marrie TJ, Harczy M, Mann E, Landymore RW, Raza A, Wang SP, Grayston TJ. Culture negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis 1990;161:127-9
27. Wessien L, Pahlson C, Friman G, Fohlman J, Lindquist O, Joahnsson C. Myocardiatitis caused by Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116:273-8
28. Saikku P, Leinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinski heart study. Ann Inter Med 1992;116:273-8
29. Kuo CC, Shor A, Campbell LA, Patton D, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9
30. Kuo CC, Grayston JT. In vitro drug susceptibility of Chlamydia sp strains TWAR. Antimicrobial Agent Chemother 1988;32:257-8
31. Chirgwin K, Roblin PM, Hammerschlag MR. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp) strain TWAR. Antimicrobial Agent Chemother 1989;33:1634-5
32. Roblin PM, Montalban G, Hammerschlag M. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrobial Agent Chemother 1994;38:1588-9
33. Hammerschlag M, Qumei KK, Roblin P. In vitro activities of azithromycin, clarithromycin, L-ofloxacin and other antibiotic against Chlamydia pneumoniae. Antimicrobial Agent Chemother 1992;36: 15734
34. Hammerschlag M, Hyman C, Roblin P. In vitro activities of five quinolones against Chlamydia pneumoniae. Antimicrobial Agent Chemother 1992;36:682-3
35. Hammerschlag M, Roblin P, M Campbell, Kolokathis A, Powell M. Microbiologic efficacy of azithromycin for the treatement of community acquired pneumonia due to Chlamydia pneumoniae in children [Abstract 2-12]. The 3rd International Conference on the macrolides, azalides and streptogramins. 24-26 January 1996, Lisbonne